AGM Statement

RNS Number : 0347S

Seeing Machines Limited

27 November 2012

 



Seeing Machines Limited

("Seeing Machines" or the "Company")

AGM Statement

Seeing Machines, the AIM-listed technology company with a focus on vision based human machine interfaces, will tomorrow hold its Annual General Meeting in Canberra, Australia at the Clifton Suites on Northbourne, 100 Northbourne Ave, Canberra ACT 2601, at 5.00pm AEDT.

The Chairman, Terry Winters, will provide the following statement at the meeting:

"The Directors believe that the combination of eye and gaze tracking with facial interpretation will be at the core of future waves of technology and applications in computing and entertainment. We believe this will provide significant opportunities, as well as challenges, for Seeing Machines in the future as we increase our R&D effort to achieve a market leading capability.

"Seeing Machines also continues to win new business, most significantly within the Driver Safety Solution (DSS) business. This represents a significant vote of confidence in the capabilities of our revamped sales force and refocused products."

Commenting on these latest developments, Chief Executive Officer, Ken Kroeger, will make the following remarks:

"DSS has been specifically designed for deployment into fleets and environments where fatigue and operator distraction pose substantial risk to personnel and equipment. We anticipate sales of DSS will grow over the next 18 months as pressure on companies to monitor and manage these risks intensifies.

"As well as selling the DSS units, we derive revenue from recurring maintenance, support services and specialist fatigue management consulting, data management, analysis and reporting services. A particular focus for us going forward will be on growing our services income through the DSSi management reporting suite. We see this as a way to enhance our client relationships and improve the quality of earnings, revenue visibility and gross margins."

Closing the meeting, Terry Winters will conclude:

"I am pleased to report that in line with the statement made with the preliminary results in September, the first few months of the current financial year commencing 1 July 2012 have shown further strengthening of the Company's sales pipeline. I am therefore very pleased to report the Board is confident in the outlook for the current financial year and beyond."

A copy of the slide presentation to made at the Annual General Meeting will be made available on the Company's website: www.seeingmachines.com

Enquiries:

Seeing Machines Limited	Terry Winters (Chairman) Ken Kroeger (Managing Director & CEO)	[phone] [phone]
finnCap Ltd	Ed Frisby/Ben Thompson (Corporate Finance) Simon Starr (Corporate Broking)	[phone]
Walbrook PR Ltd	Helen Westaway (Media Enquiries) Paul Cornelius (Investor Enquiries)	+44 (0)  20 7933 8780

About Seeing Machines Limited

Seeing Machines is a world leader in the development of premier products and applications that rely on capturing and understanding the behaviour of human faces and eyes. More information is available from our web site: www.seeingmachines.com

About Seeing Machines' Driver Safety Solution (DSS)

The Seeing Machines DSS suite is a rugged, non-invasive platform that uses cutting edge face and eye tracking techniques to deliver information on operator fatigue and distraction. The DSS has been specifically designed for deployment into fleets and environments where fatigue and operator distraction pose substantial risk to personnel and equipment and therefore need to be monitored and managed.

For more information on DSS, go to http://www.seeingmachines.com/product/dss/

About Seeing Machines' Fatigue Management Consulting

Seeing Machines supports its DSS technology with professional and scientific fatigue management consulting and training services designed to build understanding of how businesses can reduce the risk of operator  fatigue and support the readiness, implementation and acceptance of its products. Seeing Machines has developed a comprehensive fatigue management framework through combined collaboration with leading fatigue research institutions and hands on experience in the field with organisations who proactively manage fatigue. Seeing Machines also provides detailed fatigue management training for site personnel to better enable them to understand the causes of, and manage their own fatigue. For more information on fatigue management, go to http://www.seeingmachines.com/fatigue-consultancy/

About Seeing Machines' faceAPI®

faceAPI® allows users to incorporate Seeing Machines world-class face tracking technology into their own products or applications. faceAPI provides a growing suite of image-processing modules created specifically for tracking and understanding faces and facial features. These powerful tracking modules are combined into a complete API toolkit that delivers a rich stream of information that can be incorporated into our customers' own products or services. Seeing Machines faceAPI® delivers a comprehensive, integrated solution for developing products that leverage real-time face tracking. All image-processing for face tracking is handled internally, removing the need for computer vision experience. For more information on faceAPI®, go to http://www.seeingmachines.com/product/faceapi/

About Seeing Machines' faceLAB®5

Seeing Machines has been creating advanced eye tracking algorithms since the company was founded in 2000. faceLAB®5 is the organisation's eye tracking system that allows researchers to objectively measure human behavior in a wide range of operational conditions and research settings. faceLAB®'s unique eye and facial tracking solution offers users rare flexibility, portability, and accuracy. For more information on faceLAB®, go to http://www.seeingmachines.com/product/facelab/

About Seeing Machines' Truefield® Analyzer (TFA)

Currently going through its final clinical trials, the TFA will make objective visual field testing a clinical reality. It combines objectivity with 'non-contact' ease of use, making it easy for technicians and patients, giving clinicians objectivity when assessing their patients' conditions. Assessing both eyes concurrently, TFA tests are fast and can be run in both full-test and screening modes. The tests' bilateral concurrency allows the consensual light reflex to be exploited to identify bilateral asymmetries improving test accuracy. Most importantly, the TFA makes objective perimetry a clinical reality. For more information on TFA, go to http://www.seeingmachines.com/product/truefield/

 

END

 

 

AGMBKADDABDDBDB